Finance

Lists
2196:HKG
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
HK$ १७.११
-०.२३%
(-०.०४०) 1D
अक्टोबर १६, १६:०८:१४ GMT+८  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 2196...
Open
HK$ १७.३२
High
HK$ १७.५५
Low
HK$ १६.८८
Mkt. cap
६६.५४ अरब
Avg. vol.
३६.२५ लाख
Volume
२२.५२ लाख
Dividend
२.६३%
Quarterly dividend
HK$ ०.११
Ex-dividend date
२०२६ जुलाई २७
P/E ratio
११.३३
52-wk high
HK$ २४.८४
52-wk low
HK$ १४.९०
EPS
HK$ १.५१
Shares outstanding
५५.१९ करोड
No. of employees
४१ हजार
Open
HK$ १७.३२
High
HK$ १७.५५
Low
HK$ १६.८८
Mkt. cap
६६.५४ अरब
Avg. vol.
३६.२५ लाख
Volume
२२.५२ लाख
Dividend
२.६३%
Quarterly dividend
HK$ ०.११
Ex-dividend date
२०२६ जुलाई २७
P/E ratio
११.३३
52-wk high
HK$ २४.८४
52-wk low
HK$ १४.९०
EPS
HK$ १.५१
Shares outstanding
५५.१९ करोड
No. of employees
४१ हजार
News stories
From web sources and news partners
Stock Traders Daily
Stock Traders Daily
·
४ घण्टा पहिले
Understanding Momentum Shifts in (AGIX)
MarketBeat
MarketBeat
·
८ मिनेट पहिले
Sunrun (NASDAQ:RUN) Upgraded to Hold at Wall Street Zen
AOL.com
AOL.com
·
५ घण्टा पहिले
Prediction: Oracle Stock Trails the S&P 500 Through 2030
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees४०.७ हजार
Founded१९९४
Headquarters-
Sector-
Last report
२०२६ अगस्ट २५
Fiscal period
Q2 2026
- / -
Revenue / Est. (CNY)
१०.३७ अरब / १०.६६ अरब
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
९.८८ अरब
१२.२७ अरब
१०.०७ अरब
१०.३७ अरब
Cost of goods sold
५.०८ अरब
५.६५ अरब
५.०७ अरब
५.२३ अरब
Cost of revenue
५.०८ अरब
५.६५ अरब
५.०७ अरब
५.२३ अरब
Research and development expenses
१.०१ अरब
१.२८ अरब
८९.६८ करोड
१.१९ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.१० अरब
४.४४ अरब
३.२७ अरब
३.३५ अरब
Operating expense
४.०४ अरब
५.९२ अरब
४.१९ अरब
४.६३ अरब
Total operating expenses
९.१२ अरब
११.५७ अरब
९.२६ अरब
९.८६ अरब
Operating income
७५.८४ करोड
६९.९० करोड
८१.३८ करोड
५०.५३ करोड
Other non operating income
-११.६८ करोड
१०.७३ करोड
२०.२८ लाख
-१.३३ करोड
EBT including unusual items
१.१२ अरब
१.२७ अरब
१.३६ अरब
१.२३ अरब
EBT excluding unusual items
१.४९ अरब
१.१० अरब
१.२१ अरब
१.०७ अरब
Income tax expense
१६.३० करोड
८.२८ करोड
२७.७९ करोड
१५.९७ करोड
Effective tax rate
१४.५७%
६.५०%
२०.४७%
१३.००%
Other operating expenses
-९.२२ करोड
११.७६ करोड
१.९० करोड
७.४० करोड
Net income
८२.१३ करोड
८४.७३ करोड
८७.०८ करोड
८५.०६ करोड
Net profit margin
८.३१%
६.९१%
८.६४%
८.२०%
Earnings per share
-
-
-
-
Interest and investment income
१.०५ अरब
७३.२१ करोड
६८.९७ करोड
९३.८९ करोड
Interest expense
-३२.१२ करोड
-२९.१३ करोड
-२९.६५ करोड
-३१.०९ करोड
Net interest expenses
७२.७३ करोड
४४.०८ करोड
३९.३२ करोड
६२.८० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.३९ अरब
१.४७ अरब
१.५९ अरब
१.२४ अरब
Gain or loss from assets sale
२१.१७ लाख
-६.९४ करोड
-
-१.९५ लाख
AI content may include mistakes. Learn more
Google एपहरू